As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Sustainable Management Long term weight loss after discontinuing retatrutide remains the real challenge
Most common route Oral capsule, 50 to 150 mg per day, taken in the morning
Have You Felt The Glutathione Glow
A program that never sees the patient again after the first appointment is not running the protocol, it is selling the vials
Further, there are added fees for certain payment types and even a fee for requesting a refund